Table of Contents 3
List of Tables 5
List of Figures 5
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Lee's Pharmaceutical Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 16
Venture Financing 16
Tragara Pharma Raises USD13 Million in Series C Financing 16
Partnerships 18
Lee's Pharma Enters into Agreement with Shenogen Pharma 18
Lee's Pharma Enters into Agreement with Beijing Shenogen Pharma 19
ScinoPharm Enters into Agreement with CVie Therapeutics 20
INO Therapeutics Enters into Agreement with Lee's Pharma for Inomax 21
ScinoPharm Enters Into Co-Development Agreement With Lee's Pharma For Fondaparinux Sodium 22
ScinoPharm Announces Co-Development Agreement With Lee's Pharma For Travoprost And Bimatoprost 23
Licensing Agreements 24
Lee's Pharma Enters into Licensing Agreement with Alexza Pharma 24
Lee's Pharma Enters into Licensing Agreement with GC Pharma 25
Lee's Pharma Enters into Licensing Agreement with Noden Pharma 26
Lee's Pharma Enters into Licensing Agreement with Windtree Therapeutics 27
Lee's Pharma Enters into Licensing Agreement with Solasia Pharma 29
Lee's Pharma Enters into Licensing Agreement with TOT Biopharm 30
Lee's Pharma Enters into Licensing Agreement with Kato Pharma 31
Laboratorios SALVAT Enters into Licensing Agreement with Lee's Pharma 32
Lee's Pharma Enters into Licensing Agreement with Solasia Pharma for Sancuso 33
Lee's Pharma Enters into Licensing Agreement with Tragara Pharma 34
China Cardiovascular Focus Enters into Licensing Agreement with Armetheon 35
Lee's Pharma Enters into Licensing Agreement with BioQuiddity 36
Sorrento Therapeutics Enters into Licensing Agreement with Lee's Pharma for Anti-PD-L1 Antibody 37
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Thorens Cholecalciferol 38
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Attila 39
Dyax Amends Licensing Agreement With CVie Therapeutics For Kalbitor 40
RegeneRx Biopharma Enters into Licensing Agreement with Lee's Pharma for RGN-259, RGN-352 and RGN-137 41
CVie Therapeutics to Enter into Licensing Agreement with Sigma-Tau 43
CVie Therapeutics to Enter into Licensing Agreement with RostaQuo 45
CVie Therapeutics Enters into Licensing Agreement with Sigma-Tau Industrie 47
PLx Pharma Enters into Licensing Agreement with Lee's Pharma for Cardiovascular Product 48
Dilafor Enters Into Licensing Agreement With Lee's Pharma 49
Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 50
Lee's Pharma HK Enters into Licensing Agreement with Sigma-Tau Industrie Farmaceutiche Riunite 51
Equity Offering 52
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 52
CVie Therapeutics Raises USD10 Million in Private Placement of Shares 54
Asset Transactions 55
Lee's Pharma to Sell Products to China Oncology Focus for USD13.6 Million 55
Zhaoke Pharma to Sell Products to China Oncology Focus for USD0.9 Million 56
Acquisition 57
Lee's Pharmaceutical Acquires 65% Stake in China Oncology Focus 57
Lee's Pharmaceutical Holdings Ltd - Key Competitors 58
Lee's Pharmaceutical Holdings Ltd - Key Employees 59
Lee's Pharmaceutical Holdings Ltd - Locations And Subsidiaries 60
Head Office 60
Other Locations & Subsidiaries 60
Affiliate 60
Recent Developments 62
Financial Announcements 62
Aug 30, 2018: Lee's Pharmaceutical Holdings: Interim results for the six months ended 30 June 2018 62
May 24, 2018: Lee's Pharmaceutical Holdings: First Quarterly Results For The Three Months Ended 31 March 2018 65
Mar 22, 2018: Lee's Pharmaceutical Holdings:Announcement Of Annual Results For The Year Ended 31 December 2017 67
Aug 24, 2017: Lee's Pharmaceutical Holdings: Interim Results For The Six Months Ended 30 June 2017 72
Corporate Communications 74
Dec 29, 2017: Lee's Pharmaceutical Holdings: Resignation and Appointment of Non-Executive Director 74
Product News 76
03/09/2017: China FDA has Approved Zingo for Pediatric Use Needle-free Local Analgesia as Priority Review for Clinical Trial 76
Other Significant Developments 77
May 28, 2018: Lee's Pharmaceutical: Change Of Address Of Head Office And Principal Place Of Business In Hong Kong 77
Appendix 78
Methodology 78
About GlobalData 78
Contact Us 78
Disclaimer 78

List of Tables
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Lee's Pharmaceutical Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 10
Lee's Pharmaceutical Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Tragara Pharma Raises USD13 Million in Series C Financing 16
Lee's Pharma Enters into Agreement with Shenogen Pharma 18
Lee's Pharma Enters into Agreement with Beijing Shenogen Pharma 19
ScinoPharm Enters into Agreement with CVie Therapeutics 20
INO Therapeutics Enters into Agreement with Lee's Pharma for Inomax 21
ScinoPharm Enters Into Co-Development Agreement With Lee's Pharma For Fondaparinux Sodium 22
ScinoPharm Announces Co-Development Agreement With Lee's Pharma For Travoprost And Bimatoprost 23
Lee's Pharma Enters into Licensing Agreement with Alexza Pharma 24
Lee's Pharma Enters into Licensing Agreement with GC Pharma 25
Lee's Pharma Enters into Licensing Agreement with Noden Pharma 26
Lee's Pharma Enters into Licensing Agreement with Windtree Therapeutics 27
Lee's Pharma Enters into Licensing Agreement with Solasia Pharma 29
Lee's Pharma Enters into Licensing Agreement with TOT Biopharm 30
Lee's Pharma Enters into Licensing Agreement with Kato Pharma 31
Laboratorios SALVAT Enters into Licensing Agreement with Lee's Pharma 32
Lee's Pharma Enters into Licensing Agreement with Solasia Pharma for Sancuso 33
Lee's Pharma Enters into Licensing Agreement with Tragara Pharma 34
China Cardiovascular Focus Enters into Licensing Agreement with Armetheon 35
Lee's Pharma Enters into Licensing Agreement with BioQuiddity 36
Sorrento Therapeutics Enters into Licensing Agreement with Lee's Pharma for Anti-PD-L1 Antibody 37
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Thorens Cholecalciferol 38
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Attila 39
Dyax Amends Licensing Agreement With CVie Therapeutics For Kalbitor 40
RegeneRx Biopharma Enters into Licensing Agreement with Lee's Pharma for RGN-259, RGN-352 and RGN-137 41
CVie Therapeutics to Enter into Licensing Agreement with Sigma-Tau 43
CVie Therapeutics to Enter into Licensing Agreement with RostaQuo 45
CVie Therapeutics Enters into Licensing Agreement with Sigma-Tau Industrie 47
PLx Pharma Enters into Licensing Agreement with Lee's Pharma for Cardiovascular Product 48
Dilafor Enters Into Licensing Agreement With Lee's Pharma 49
Lee's Pharma Enters Into Licensing Agreement With GP Pharm For Leuprolide 50
Lee's Pharma HK Enters into Licensing Agreement with Sigma-Tau Industrie Farmaceutiche Riunite 51
Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 52
CVie Therapeutics Raises USD10 Million in Private Placement of Shares 54
Lee's Pharma to Sell Products to China Oncology Focus for USD13.6 Million 55
Zhaoke Pharma to Sell Products to China Oncology Focus for USD0.9 Million 56
Lee's Pharmaceutical Acquires 65% Stake in China Oncology Focus 57
Lee's Pharmaceutical Holdings Ltd, Key Competitors 58
Lee's Pharmaceutical Holdings Ltd, Key Employees 59
Lee's Pharmaceutical Holdings Ltd, Subsidiaries 60
Lee's Pharmaceutical Holdings Ltd, Affiliate 60

List of Figures
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Lee's Pharmaceutical Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Lee's Pharmaceutical Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 12